Only about one in five people with cancer enroll in clinical trials, and the largest barrier to participation may be far ...
Tens of millions of Americans turn to cannabis products every week to try to ease their pain, calm their anxiety, get more ...
Humans ask what things mean. Animals move on. That difference explains both our brilliance and much of our psychological ...
It is a common stereotype that autistic people do not have empathy. This stereotype is false and not backed up by the latest ...
Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.
With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former ...
Bristol Myers Squibb needs more time to run a late-stage study for one of its most promising drugs, delaying a readout that’s key to the company’s future. Yet the stock BMY was up about 6% on ...
Cognitive impairments in schizophrenia are widespread, persistent throughout the illness course, and significantly impact quality of life and functional outcomes. Integrating neuropsychological ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...
According to Towards Healthcare market projections, the U.S. clinical trials market is expected to grow from USD 43.45 billion in 2025 to USD 80.42 billion by 2035, reflecting a CAGR of 6.35%, due to ...
Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Endocrinologist Daniel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback